{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/parvovirus-b19-infection/management/pregnant-women/","result":{"pageContext":{"chapter":{"id":"25b4fecb-ae9d-58f7-ad14-7ace595c0800","slug":"pregnant-women","fullItemName":"Scenario: Pregnant women","depth":2,"htmlHeader":"<!-- begin field e8dbd0cd-2ef5-415a-af00-7377d6a61d38 --><h2>Scenario: Pregnant women</h2><!-- end field e8dbd0cd-2ef5-415a-af00-7377d6a61d38 -->","summary":"Covers the management of pregnant women with suspected and confirmed parvovirus B19 infection, or those who have been in contact with a person with suspected or confirmed parvovirus B19 infection.","htmlStringContent":"<!-- begin item 0c101576-1ae2-4ef4-8303-8f725aa77b8c --><!-- begin field b8bb1549-e2a2-413b-911e-acbd00852f94 --><p>From age 13 years onwards (Female).</p><!-- end field b8bb1549-e2a2-413b-911e-acbd00852f94 --><!-- end item 0c101576-1ae2-4ef4-8303-8f725aa77b8c -->","topic":{"id":"a0e6adce-f85f-55b0-8d7f-3b5e75836d40","topicId":"3ea4cf87-3eee-4e3f-a6d0-b0ee3a4ee3ad","topicName":"Parvovirus B19 infection","slug":"parvovirus-b19-infection","lastRevised":"Last revised in February 2017","chapters":[{"id":"c45face5-dc30-586a-b7ca-3b24305bd068","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cc09231e-bb7a-5379-aeec-7c830288098e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2971cfc1-4839-5be6-b726-20b9383ae294","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"020d2cdb-0f7f-5bc0-a249-98fc3690b68c","slug":"changes","fullItemName":"Changes"},{"id":"af1bc49c-d614-521b-b6f3-ad084fc2aed9","slug":"update","fullItemName":"Update"}]},{"id":"7c9f0c10-cf1d-5723-856f-e0bc2d270210","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bb1635ce-433b-5f39-a93a-27b4488878c5","slug":"goals","fullItemName":"Goals"},{"id":"3c7eed51-287a-5bcb-8519-40ef7f5784aa","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"291f85a1-8911-59d4-82d6-62ce4daff1c0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e66b8854-eb00-59b9-85d9-f50343f36470","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ce817770-4fbe-5b47-b4ed-56b723012488","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"faa5c5db-5837-5cbd-8e56-78bc7ac42137","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0f0e8f26-e2c7-5de3-b012-e340b25ad622","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"afcf1b63-41ac-5295-91b5-4e19bc828249","slug":"definition","fullItemName":"Definition"},{"id":"60a93741-3863-58bb-8394-a33804062373","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1cfa61b6-71af-5e94-9e40-95b29e9f97dc","slug":"complications","fullItemName":"Complications"},{"id":"034c66fb-a99f-5a21-a031-d557dc647301","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"53019719-ec11-57d5-afd3-3ed2e9939168","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e7eca192-b219-5e71-8ecd-6d2e6cf0f3da","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"2b824d0f-b0b0-5801-8def-a38d172c2532","slug":"investigations","fullItemName":"Investigations"},{"id":"7daba43a-1410-5703-8a94-b6530a5dfccc","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b0275eae-f19c-57fb-834c-03df7c6dcea3","fullItemName":"Management","slug":"management","subChapters":[{"id":"73c2e9d4-b567-504f-9b28-36966a247590","slug":"children-adults-not-pregnant","fullItemName":"Scenario: Children and adults (not pregnant)"},{"id":"25b4fecb-ae9d-58f7-ad14-7ace595c0800","slug":"pregnant-women","fullItemName":"Scenario: Pregnant women"}]},{"id":"bdf3d270-5563-5eb4-804f-68fce2e7e7dd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"73875656-8429-5584-82e6-d06c0a5f52ea","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8dc117ba-c373-5ee0-a7aa-fc63a62a7067","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"24bd5691-28ce-53b1-be8b-f0e51e40db4b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b35b969-66a8-5431-900a-a524f0bf1a89","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"63ad51a8-8325-52f2-a254-ed3ccae9f508","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"174a35a7-6fa3-58ef-9e06-6325d5f0111b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c6c0fc6f-31f8-5681-bbce-4ed5b6b16e4e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b0275eae-f19c-57fb-834c-03df7c6dcea3","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"147f7ae0-ced1-57d0-901a-21d08fcddea0","slug":"management-of-suspected-infection-in-pregnancy","fullItemName":"Management of suspected infection in pregnancy","depth":3,"htmlHeader":"<!-- begin field 433f9631-ca5e-480a-a8fe-2f345dfd7854 --><h3>How should I manage suspected parvovirus B19 infection in pregnancy?</h3><!-- end field 433f9631-ca5e-480a-a8fe-2f345dfd7854 -->","summary":null,"htmlStringContent":"<!-- begin item 975280ac-5bce-41fd-b1ed-4856f0ec22d7 --><!-- begin field 5d01e259-7f16-4f0e-b5a5-8636e76c3aa2 --><p><strong>If parvovirus B19 infection is suspected at any stage of pregnancy, be aware that the clinical features may be indistinguishable from rubella infection.</strong></p><ul><li><strong>Assess the woman's:</strong><ul><li>Gestation of pregnancy and expected date of delivery.</li><li>Date of onset, <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/diagnosis/\">clinical features</a>, and type and distribution of any rash and associated illness.</li><li>Previous relevant history of infection, immunoglobulin G (IgG) antibody testing, and measles/rubella vaccination status (with dates/places).</li><li>Known <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/pregnant-women/#management-of-possible-exposure-in-pregnancy\">contact</a> with any person with a potentially infectious rash or illness (with dates of contact).</li></ul></li><li><strong>Contact the local virology, microbiology, or infectious diseases department immediately for further advice on <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/investigations/\">laboratory investigations</a> and monitoring to arrange.</strong> This should include:<ul><li>Confirming the diagnosis of parvovirus B19 infection.</li><li>Checking for rubella infection at the same time, irrespective of the woman's previous testing or immunization status to rubella. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rubella/\">Rubella</a> for more information on laboratory tests to arrange and subsequent management.</li></ul></li><li><strong>Give advice on sources of information and support,</strong> such as the NHS patient information leaflets <a data-hyperlink-id=\"5f2d0307-a5f6-4fd7-845d-a98e01240067\" href=\"https://www.nhs.uk/conditions/slapped-cheek-syndrome/\" target=\"_blank\">Slapped cheek syndrome</a>.</li><li><strong>Give advice on self-management strategies for symptom relief,</strong> including:<ul><li>Getting rest and drinking adequate fluids.</li><li>Using simple analgesia, such as paracetamol, if needed and appropriate. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> for more prescribing information.</li></ul></li><li><strong>Advise the woman that:</strong><ul><li>It is not usually necessary to stay off work if symptoms are controlled, as the infection is no longer contagious by the time the rash or arthropathy develops.</li><li>If the woman has not been fully immunized against rubella or got a documented history of previous rubella infection, it may be sensible to avoid contact with other pregnant women while any rash is present, until her rubella status is known.</li></ul></li><li><strong>Contact the local virology, microbiology, or infectious diseases department for further advice</strong> if there is any uncertainty about recommendations on isolation of pregnant women with suspected infection.</li></ul><!-- end field 5d01e259-7f16-4f0e-b5a5-8636e76c3aa2 --><!-- end item 975280ac-5bce-41fd-b1ed-4856f0ec22d7 -->","subChapters":[{"id":"cb69d258-3d9d-5d59-bfea-d9bba34c74df","slug":"basis-for-recommendation-564","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 0364a8a8-60d5-405c-81b2-b2a6f61001d4 --><h4>Basis for recommendation</h4><!-- end field 0364a8a8-60d5-405c-81b2-b2a6f61001d4 -->","summary":null,"htmlStringContent":"<!-- begin item 5640242c-d100-4b0e-893f-c85999a0c8d4 --><!-- begin field 61db7fb6-6223-4ac6-a6c7-999f3198b239 --><h5>Suspected infection at any stage of pregnancy</h5><ul><li>The recommendation on assessing a woman with suspected infection at any stage of pregnancy is extrapolated from expert opinion in the Public Health England (PHE) publication <em>UK Standards for microbiology investigations. Investigation of pregnant women exposed to non-vesicular rash</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2015</a>].<ul><li>Although the risks of fetal loss and hydrops fetalis are highest if parvovirus B19 infection is contracted within the first 20 weeks of pregnancy, there remains a low theoretical risk of transmission and adverse fetal outcome after this gestation.</li></ul></li></ul><h5>Assessment of the woman</h5><ul><li>The recommendations on how to assess a pregnant woman with suspected parvovirus B19 infection are based on expert opinion in the PHE publication <em>Guidance on viral rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>] and expert opinion in a review article on common skin conditions in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Allmon, 2015</a>].<ul><li>The rash and clinical features of parvovirus B19 infection may be indistinguishable from rubella infection, so a pregnant woman with a rubella-like rash requires assessment for both infections.</li></ul></li></ul><h5>Arranging laboratory investigations for parvovirus B19 and rubella infection</h5><ul><li>The recommendation to contact the local virology, microbiology, or infectious diseases department for specialist advice immediately is extrapolated from expert opinion in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li><li>The recommendation to arrange investigations for rubella irrespective of the woman's previous antibody test results or immunization status is based on expert opinion in the PHE publication <em>Guidance on viral rash in pregnancy</em>, as there is a small chance of past laboratory or documentation error, failed antibody response to immunization, or symptomatic rubella re-infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>].</li></ul><h5>Advice on self-management strategies</h5><ul><li>The recommendations on self-management strategies for symptom relief are extrapolated from expert opinion in a review article on parvovirus B19 infection and roseola infantum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">O&#39;Grady, 2014</a>] and a review article on common skin conditions in childhood [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Allmon, 2015</a>].</li></ul><h5>Advice on exclusion from work and isolation from at-risk contacts</h5><ul><li>The recommendation on not needing to stay off work is extrapolated from expert opinion in the PHE publication <em>Guidance on infection control in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2016</a>].<ul><li>In working adults, there is no need for exclusion from work, as by the time the rash has developed, the period of infectivity has passed.</li></ul></li><li>The recommendation for women with uncertain rubella immunization status to avoid contact with other pregnant women is pragmatic, as it is difficult to clinically differentiate between parvovirus B19 and rubella infection, and both may have serious or life-threatening sequelae for the fetus (or more rarely, the mother).</li></ul><h5>Seeking specialist advice</h5><ul><li>The recommendation on seeking advice from the local virology, microbiology, or infectious diseases department if there is uncertainty about ongoing management is based on expert opinion in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li></ul><!-- end field 61db7fb6-6223-4ac6-a6c7-999f3198b239 --><!-- end item 5640242c-d100-4b0e-893f-c85999a0c8d4 -->","subChapters":[]}]},{"id":"78fa01f8-9d4c-5f02-9bad-56be85029a87","slug":"management-of-possible-exposure-in-pregnancy","fullItemName":"Management of possible exposure in pregnancy","depth":3,"htmlHeader":"<!-- begin field 2cb9a2d6-3b2c-4393-9c9c-e6f3fa4da043 --><h3>How should I manage possible exposure to parvovirus B19 infection in pregnancy?</h3><!-- end field 2cb9a2d6-3b2c-4393-9c9c-e6f3fa4da043 -->","summary":null,"htmlStringContent":"<!-- begin item 8830b149-8f1d-4a33-8eb9-19f3f2a77d6e --><!-- begin field 9d5226cc-fba3-4057-9f62-7840b54b57d8 --><p><strong>For women who have had possible exposure to parvovirus B19 infection at any stage of pregnancy:</strong></p><ul><li><strong>Assess whether, and when, there has been significant contact with any person with a potentially infectious rash or illness (before the onset of rash, if any).</strong><ul><li>Significant contact is defined as being in the same room for 15 minutes or more, or face-to-face contact with the person, within the previous 3 weeks.</li><li>Be aware that household (rather than occupational) exposure is the most important source of infection in pregnancy.</li><li>If the woman is known to be susceptible to rubella, contact for less than 15 minutes should also be considered as possible exposure. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rubella/\">Rubella</a> for more information on the criteria for immunity, and management of women who are susceptible to rubella.</li></ul></li><li><strong>Assess the woman's:</strong><ul><li>Gestation of pregnancy and expected date of delivery.</li><li>Previous relevant history of infection, immunoglobulin G (IgG) antibody testing, and measles/rubella vaccination status (with dates/places).</li></ul></li><li><strong>Contact the local virology, microbiology, or infectious diseases department immediately for further advice on <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/investigations/\">laboratory investigations</a> to arrange</strong> to check for asymptomatic parvovirus B19 (and rubella infection, unless there is previous documented laboratory evidence that the woman is rubella immune).<ul><li>Blood should be tested as soon after contact as possible.</li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rubella/\">Rubella</a> for more information on the criteria for immunity, and management of women who are susceptible to rubella.</li></ul></li><li><strong>Advise the woman to avoid contact with</strong> other pregnant women and people at risk of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">complications</a>, until she is known to be uninfected, immune to infection, or no longer potentially infectious.<ul><li>The infectious period is 7–10 days before the rash (if any) develops, until one day after the rash appears.</li><li>If there is any uncertainty on the recommendations on isolation from other at-risk people, contact the local virology, microbiology, or infectious diseases department for further advice.</li></ul></li><li><strong>If the woman develops symptoms of active infection or if infection is confirmed,</strong> see the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/pregnant-women/#management-of-suspected-infection-in-pregnancy\">How should I manage suspected parvovirus B19 infection in pregnancy?</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/pregnant-women/#management-of-confirmed-infection-in-pregnancy\">How should I manage confirmed parvovirus B19 infection in pregnancy?</a> for more information on management.</li></ul><!-- end field 9d5226cc-fba3-4057-9f62-7840b54b57d8 --><!-- end item 8830b149-8f1d-4a33-8eb9-19f3f2a77d6e -->","subChapters":[{"id":"313f8f30-af63-5bb0-b553-ad24143a015e","slug":"basis-for-recommendation-f16","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field afc4e6b7-7ab1-4d69-bb6c-3dfde3d795cd --><h4>Basis for recommendation</h4><!-- end field afc4e6b7-7ab1-4d69-bb6c-3dfde3d795cd -->","summary":null,"htmlStringContent":"<!-- begin item f1667df8-7e65-4594-ba7e-80ca05ddc7c4 --><!-- begin field c10e6b47-1457-4ae4-85e0-7ba2960275ab --><h5>Possible exposure at any stage of pregnancy</h5><ul><li>The recommendation on assessing a woman with possible exposure at any stage of pregnancy is based on expert opinion in the Public Health England (PHE) publication <em>UK Standards for microbiology investigations. Investigation of pregnant women exposed to non-vesicular rash</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2015</a>].<ul><li>Although the risks of fetal loss and hydrops fetalis are highest if parvovirus B19 infection is contracted within the first 20 weeks of pregnancy, there remains a low theoretical risk of transmission and adverse fetal outcomes after this gestation.</li></ul></li></ul><h5>Definition of significant contact</h5><ul><li>The information on what constitutes significant contact is based on expert opinion in the PHE publication <em>Guidance on viral rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>].<ul><li>The definition is based on research on varicella (chickenpox) transmission. As varicella is significantly more infectious than parvovirus B19, this is likely to be a conservative definition. Determining contact with parvovirus B19 may be difficult, because exposure to the virus occurs before the development of rash or other symptoms, and about 20% of children and up to 50% of adults are asymptomatic.</li></ul></li><li>The information that the greatest risk of transmission is from a household (rather than occupational) contact is based on expert opinion in the PHE publication <em>Guidance on infection control in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2016</a>].</li></ul><h5>Assessment of the woman</h5><ul><li>The recommendations on how to assess a pregnant woman with possible exposure to parvovirus B19 infection are extrapolated from expert opinion in the PHE publication <em>Guidance on viral rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>].</li></ul><h5>Arranging laboratory investigations for parvovirus B19 and rubella infection</h5><ul><li>The recommendation to contact the local virology, microbiology, or infectious diseases department for specialist advice immediately is based on expert opinion in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].<ul><li>Immediate investigation of a pregnant woman is important because maternal asymptomatic infection is at least as likely to infect the fetus and cause potential complications as symptomatic infection. In addition, if infection is identified early, specialist interventions may reduce the risk of adverse outcomes such as hydrops fetalis and fetal death [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>]. Up to 70% of infected pregnant women will be asymptomatic [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">SOGC, 2014</a>].</li></ul></li><li>The recommendation to arrange investigations for rubella unless the woman is known to be immune is based on expert opinion in the PHE publication <em>UK Standards for microbiology investigations. Investigation of pregnant women exposed to non-vesicular rash</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2015</a>].<ul><li>The rash and clinical features of parvovirus B19 infection may be indistinguishable from rubella infection, so a pregnant woman with a rubella-like rash requires assessment for both infections if she is non-immune. Rubella is however rare in the UK, and most women receive antenatal screening for rubella antibodies in the early stages of pregnancy.</li></ul></li></ul><h5>Advice on measures to reduce the risk of transmission</h5><ul><li>The recommendation on avoiding contact with other pregnant women and at-risk groups is extrapolated from expert opinion in the PHE publication <em>UK Standards for microbiology investigations. Investigation of pregnant women exposed to non-vesicular rash</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2015</a>].<ul><li>These people are at increased risk of developing serious or life-threatening complications from parvovirus B19 infection, and immunocompromised people may not present with typical symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].</li></ul></li><li>The information on the infectious period is based on expert opinion in the PHE publication <em>UK Standards for microbiology investigations. Investigation of pregnant women exposed to non-vesicular rash</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2015</a>] and a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li><li>The recommendation on seeking specialist advice if there is uncertainty regarding ongoing management is based on expert opinion in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li></ul><p> </p><!-- end field c10e6b47-1457-4ae4-85e0-7ba2960275ab --><!-- end item f1667df8-7e65-4594-ba7e-80ca05ddc7c4 -->","subChapters":[]}]},{"id":"454b20a1-a347-500e-8c44-cabc9998bebb","slug":"management-of-confirmed-infection-in-pregnancy","fullItemName":"Management of confirmed infection in pregnancy","depth":3,"htmlHeader":"<!-- begin field da90a604-f093-414b-8c67-e2bb73b3fe14 --><h3>How should I manage confirmed parvovirus B19 infection in pregnancy?</h3><!-- end field da90a604-f093-414b-8c67-e2bb73b3fe14 -->","summary":null,"htmlStringContent":"<!-- begin item 45e7eb25-db7b-43d3-97f3-b3e0d63ee5ac --><!-- begin field 5e68d46b-3c28-4a73-8b12-9bdebc22bea4 --><p><strong>If parvovirus B19 infection is confirmed in a pregnant woman following <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/investigations/\">laboratory investigations</a>:</strong></p><ul><li><strong>Arrange urgent referral to a specialist in fetal medicine</strong> (to be seen within 4 weeks of<strong> </strong>the onset of symptoms or estimated time of seroconversion) for ongoing <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/pregnant-women/#specialist-obstetric-monitoring-management\">monitoring and management</a>.<ul><li>Advise the woman that transmission to the fetus is unlikely, and specialist fetal monitoring will be arranged. If fetal transmission occurs, there may be effective specialist treatment options available.</li></ul></li><li><strong>If rubella infection is confirmed,</strong> see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rubella/\">Rubella</a> for more information on specialist management.</li><li><strong>Arrange admission or referral for the woman if there are suspected acute <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">complications</a> in pregnancy:</strong><ul><li>Arrange an urgent full blood count and reticulocyte count (if not already done) or emergency admission for women with symptoms of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">severe or aplastic anaemia</a> (such as breathlessness, lightheadedness, lethargy, or confusion), depending on clinical judgement.<ul><li>If there is any uncertainty about appropriate management, seek specialist advice from a haematologist.</li></ul></li><li>Arrange an emergency obstetric admission if there is suspected <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">maternal pre-eclampsia-like syndrome</a>.</li></ul></li></ul><!-- end field 5e68d46b-3c28-4a73-8b12-9bdebc22bea4 --><!-- end item 45e7eb25-db7b-43d3-97f3-b3e0d63ee5ac -->","subChapters":[{"id":"ae396e95-a70c-53b7-90d2-08f9885ca19f","slug":"specialist-obstetric-monitoring-management","fullItemName":"Specialist obstetric monitoring and management","depth":4,"htmlHeader":"<!-- begin field 391cf6b3-b6f4-48e0-a764-a70b00c9e5be --><h4>Specialist obstetric monitoring and management</h4><!-- end field 391cf6b3-b6f4-48e0-a764-a70b00c9e5be -->","summary":null,"htmlStringContent":"<!-- begin item 19effe07-550a-4cc4-a16b-a70b00c9e341 --><!-- begin field a7a444c1-74ad-416e-a1af-a70b00c9e5be --><ul><li><strong>Specialist fetal monitoring may include:</strong><ul><li>Serial fetal ultrasound scans and Doppler assessment to detect fetal anaemia, heart failure, and hydrops. Ultrasound scanning may start around 4 weeks after the onset of symptoms or estimated time of seroconversion.<ul><li>Hydrops fetalis may present on ultrasound with the development of ascites and thickening and enlargement of the fetal heart.</li></ul></li></ul></li><li><strong>If there is suspected fetal hydrops, options include:</strong><ul><li>Parvovirus B19 viral DNA detection in amniotic fluid.</li><li>Fetal blood sampling and intrauterine red blood cell transfusion, which may reduce the fetal mortality rate.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Lamont, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">SOGC, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">UK National Screening Committee, 2014</a>]</p><!-- end field a7a444c1-74ad-416e-a1af-a70b00c9e5be --><!-- end item 19effe07-550a-4cc4-a16b-a70b00c9e341 -->","subChapters":[]},{"id":"2ec4007c-537f-5fef-9013-00d0db7131a5","slug":"basis-for-recommendation-91e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 77a6aad3-b7dd-4adb-94c0-6be46062b051 --><h4>Basis for recommendation</h4><!-- end field 77a6aad3-b7dd-4adb-94c0-6be46062b051 -->","summary":null,"htmlStringContent":"<!-- begin item 91e283b9-270a-42c7-be6f-58f5d17af7ff --><!-- begin field 693fe7a4-6eaa-450a-93d2-e93cd75d1c94 --><h5>Arranging urgent referral to a specialist in fetal medicine</h5><ul><li>The recommendation on arranging urgent referral to a specialist fetal medicine unit is based on expert opinion in the Public Health England (PHE) publication <em>Guidance on viral rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>] and a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].<ul><li>Specialist units will have resources to provide specialist counselling, serial fetal monitoring, and intervention if needed.</li></ul></li></ul><h5>Arranging admission or referral if suspected complications</h5><ul><li>The recommendation on checking an urgent full blood count (including reticulocyte count) if severe or aplastic anaemia is suspected is extrapolated from expert opinion in a review article on parvovirus B19 infection and people with sickle cell disease and thalassaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].<ul><li>Rarely, parvovirus B19 may cause anaemia in healthy people, or parvovirus B19-induced anaemia may be the first indication of an underlying haematological disorder.</li></ul></li><li>The recommendation on seeking specialist advice from a haematologist if there is any uncertainty about management if anaemia or reticulocytosis is confirmed, is pragmatic based on what CKS considers to be good clinical practice.</li><li>The recommendation on arranging emergency admission if there is suspected maternal pre-eclampsia-like syndrome is based on expert opinion in the Society of Obstetricians and Gynaecologists of Canada clinical practice guideline <em>Investigation and management of non-immune fetal hydrops</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Desilets, 2013</a>], as this condition is potentially life-threatening to the mother.</li></ul><!-- end field 693fe7a4-6eaa-450a-93d2-e93cd75d1c94 --><!-- end item 91e283b9-270a-42c7-be6f-58f5d17af7ff -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}